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Abstract
Phages shape the structure of natural bacterial communities and can be effective therapeu-
tic agents. Bacterial resistance to phage infection, however, limits the usefulness of phage
therapies and could destabilise community structures, especially if individual resistance
mutations provide cross-resistance against multiple phages. We currently understand very
little about the evolution of cross-resistance in bacteria–phage interactions. Here we show
that the network structure of cross-resistance among spontaneous resistance mutants of
Pseudomonas aeruginosa evolved against each of 27 phages is highly modular. The cross-
resistance network contained both symmetric (reciprocal) and asymmetric (nonreciprocal)
cross-resistance, forming two cross-resistance modules defined by high within- but low
between-module cross-resistance. Mutations conferring cross-resistance within modules
targeted either lipopolysaccharide or type IV pilus biosynthesis, suggesting that the modu-
larity of cross-resistance was structured by distinct phage receptors. In contrast, between-
module cross-resistance was provided by mutations affecting the alternative sigma factor,
RpoN, which controls many lifestyle-associated functions, including motility, biofilm forma-
tion, and quorum sensing. Broader cross-resistance range was not associated with higher
fitness costs or weaker resistance against the focal phage used to select resistance. How-
ever, mutations in rpoN, providing between-module cross-resistance, were associated with
higher fitness costs than mutations associated with within-module cross-resistance, i.e., in
genes encoding either lipopolysaccharide or type IV pilus biosynthesis. The observed struc-
ture of cross-resistance predicted both the frequency of resistance mutations and the ability
of phage combinations to suppress bacterial growth. These findings suggest that the evolu-
tion of cross-resistance is common, is likely to play an important role in the dynamic struc-
ture of bacteria–phage communities, and could inform the design principles for phage
therapy treatments.
Author summary
Phage therapy is a promising alternative to antibiotics for treating bacterial infections. Yet
as with antibiotics, bacteria readily evolve resistance to phage attack, including cross-
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resistance that protects against multiple phages at once and so limits the usefulness of
phage cocktails. Here we show, using laboratory experimental evolution of resistance
against 27 phages in P. aeruginosa, that cross-resistance is common and determines
the ability of phage combinations to suppress bacterial growth. Using whole-genome
sequencing, we show that cross-resistance is most common against multiple phages that
use the same receptor but that global regulator mutations provide generalist resistance,
probably by simultaneously affecting the expression of multiple different phage receptors.
Future trials should test if these features of cross-resistance evolution translate to more
complex in vivo environments and can therefore be exploited to design more effective
phage therapies for the clinic.
Introduction
Natural microbial communities are comprised of complex networks of species interactions,
wherein each species may be engaged in ecological interactions with many other species [1–3].
In this community context, the evolutionary response of a focal species to a given pairwise spe-
cies interaction can promote an ‘evolutionary cascade’ through the adjacent interacting species
[4,5]. For bacteria–phage interaction networks, we expect that the impact of a given phage
resistance mutation will depend on the connectivity of that bacterial host within the commu-
nity network [6] and the degree of cross-resistance provided by the mutation against other
phage species in the network [7]. Whereas the statistical structure of interactions in bacteria–
phage networks has been well studied [8], the structure and underlying genetic basis of cross-
resistance networks remain poorly understood. This considerably limits our ability to predict
how cross-resistance evolution affects bacteria–phage communities across different environ-
mental, agricultural, and clinical contexts.
The extent of cross-resistance provided by a given resistance mutation is likely to depend
on the genetic correlations between bacterial resistance traits selected by the different phage
species. Cross-resistance is likely for cases of positive genetic correlation; for example, binding
to shared receptors can cause synergistic pleiotropy between specific resistances—for instance,
a mutation in the lipopolysaccharide (LPS) biosynthesis pathway is likely to promote cross-
resistance to other phages that also adsorb to LPS [9,10]. In contrast, cross-resistance is less
likely if there is antagonistic pleiotropy, in which resistance to one phage increases susceptibil-
ity to an alternative phage (for example, through replacement of a clustered regularly inter-
spaced short palindromic repeat [CRISPR] spacer [11]), or no genetic correlation—for
instance, if the phages bind to different receptors and accumulation of multiple resistance
mutations is therefore required [12]. Because individual resistance mechanisms frequently
incur fitness costs by impairing the normal functioning of the molecule acting as the phage
receptor, accumulation of multiple resistance mechanisms may be limited by their combined
fitness costs, particularly if there is negative epistasis among the fitness costs of resistance
mutations [7,13]. Even though pleiotropic costs should limit the evolution of generalist resis-
tance, cross-resistance is commonly observed [14,15]. Most of this evidence is, however, based
on relatively simple phage communities, and it is less clear how the range of cross-resistance
provided by different resistance mutations is related to the magnitude of fitness costs in more
complex bacteria–phage networks.
Understanding the structure of bacterial cross-resistance to phage infection also has impor-
tant applied implications with relation to phage therapy, i.e., the use of phages as antimicrobi-
als to treat bacterial infections [16]. Phage cocktails (i.e., combinations of different phages)
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have been shown to delay the evolution of resistance in bacteria, both in vitro [17] and in vivo
[18], compared to challenge with a single phage. Effective phage cocktails often contain phages
that target different bacterial receptors (for example, [19,20]), and as a result, multiple resis-
tance mutations in different receptor genes are required to provide resistance to all the phages
present in the cocktail [21]. The requirement for bacteria to accumulate multiple resistance
mutations is thought to enhance the evolutionary robustness of phage cocktails because there
is a lower probability of resistance emerging. Furthermore, resistance to multiple phages is
likely to be associated with greater fitness costs assuming additivity of fitness costs associated
with each resistance mutation [7]. These assumptions may not apply, however, if very general-
ist cross-resistance is available via a single mutation affecting the expression of multiple
phage receptors. This suggests therefore that minimising the potential for cross-resistance
could be a key feature of effective phage cocktail design. However, this has not been tested
experimentally.
Here we determined the network structure and genetic basis of cross-resistance against a
collection of 27 phages infecting the opportunistic human pathogen, P. aeruginosa. The cross-
resistance network contained both symmetric (reciprocal) and asymmetric (nonreciprocal)
interactions, forming two cross-resistance modules defined by high within- but low between-
module cross-resistance. Within cross-resistance modules, resistance mutations targeted dis-
tinct phage receptors, whereas between-module cross-resistance was caused by mutations tar-
geting a global regulator likely to control the expression of multiple phage receptors. The
range of cross-resistance provided by a mutation was not correlated to its fitness cost, except
that global regulator mutations causing between-module cross-resistance were costlier than
mutations causing within-module cross-resistance. Furthermore, the degree and symmetry of
cross-resistance predicted the ability of phage combinations to suppress bacterial growth and
the frequency of resistance mutations. Together, our data suggest that an understanding of
cross-resistance interactions could help to predict the impact of resistance evolution on host–
parasite community structure and aid the rational design of therapeutic phage cocktails.
Results
Variation in cross-resistance provided by individual resistance mutations
To determine the extent of cross-resistance, we tested 263 spontaneous resistant mutants of
P. aeruginosa PAO1 selected against each of 27 phages (i.e., 10 resistant mutants were selected
against each focal phage; 7 mutants were discarded because of persistent phage contamination)
for their ability to resist infection by all other phages (cross-resistance). Resistance was deter-
mined by measuring relative bacterial growth (RBG) of each spontaneous mutant in the pres-
ence versus absence of each phage where mutants were classified as resistant if their RBG
exceeded a binary resistance threshold (RBG = 0.798; calculated as the 95% confidence interval
of a normal distribution modelled over the peak of resistance within the complete RBG distri-
bution [S1 Fig; S1 Data]). We observed variation in the pattern and range of cross-resistance
among spontaneous resistance mutations (Fig 1; S2 Fig). First, the degree of cross-resistance
selected by the different focal phages varied extensively, ranging from conferring resistance
against fewer than 10% to up to 80% of all phages (S2 Fig; Kruskal-Wallis ġ226 = 66.6,
p< 0.0001). Second, both focal resistance and cross-resistance phenotypes varied considerably
between independently evolved resistant mutants selected against the same focal phage (S2
Fig). Together, these results suggest that the magnitude of cross-resistance depends on the
focal resistance selected and that multiple resistance mechanisms may exist against the same
focal phage, resulting in different levels of cross-resistance between independent replicate
mutants.
Evolution of cross-resistance
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Cross-resistance range was not limited by fitness costs or strength of focal
resistance
The evolution of broad, generalist cross-resistance could be constrained if it was associated
with relatively higher costs compared to more specialised resistance or if mutations providing
cross-resistance concomitantly provided only weak resistance against the focal phage. In con-
trast, while all resistance mutations selected against focal phage were costly (Fig 2A; one-sided
t tests: all p< 0.005), we observed no overall relationship between the range of cross-resistance
provided by resistance mutations and their associated costs (Fig 2A; linear mixed effects
model: t236 = −0.655, p = 0.513). Moreover, we observed a positive relationship between the
strength of focal resistance and the range of cross-resistance provided by resistance mutations
(Fig 2B; linear mixed effects model: t245 = 15.09, p< 0.0001). These results suggest that the evo-
lution of cross-resistance is unlikely to be constrained by trade-offs due to associated fitness
costs or the strength of the focal resistance.
The structure of the cross-resistance network
Network analysis of the directional cross-resistance frequency (CRF) of all pairwise phage
combinations produced a cross-resistance network with two distinct modules (Fig 1). Within
each module, all possible pairwise phage combinations were connected by some degree of
cross-resistance, whereas cross-resistance between the two modules was more limited
Fig 1. Quantitative cross-resistance network. Each node represents a phage strain, and arrows between nodes show directional
CRF between two phages. The line widths are scaled by the proportion of replicate mutants selected against the focal phage (origin
node) that have resistance above the binary threshold (S1 Fig) to the second phage (target node). Node colours define resistance
modules identified using an ‘edge-betweenness’ algorithm. A subset of 20 phage strains that all showed strong symmetric cross-
resistance were grouped together as the node labelled ‘Other’. CRF, cross-resistance frequency.
https://doi.org/10.1371/journal.pbio.2006057.g001
Evolution of cross-resistance
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(narrower arrows between nodes denote low frequency of cross-resistance interactions) and
observed only between a small proportion of all the potential phage pairs (8/92, i.e., around
8.7%, Fig 1). Within modules, asymmetric (i.e., nonreciprocal) cross-resistance was more com-
mon within module 1, whereas module 2 was dominated by symmetric (i.e., reciprocal) cross-
resistance (note that the ‘other’ node in module 2 of Fig 1 contains a subset of 194 mutants
providing consistently strong symmetric cross-resistance against 20 phages). The high degree
of symmetric cross-resistance observed in module 2 could not be explained simply by the
genetic similarity of the focal phages as estimated from their random amplification of poly-
morphic DNA (RAPD) PCR banding patterns (S4 Fig; S3 Data). Between-module cross-resis-
tance was always asymmetric and typically from module 1 to module 2 (Fig 1). This network
structure was robust to the binary threshold value used to classify resistance, although using
lower thresholds led to increased numbers of asymmetric connections between modules (S3
Fig). Symmetric cross-resistance is likely to occur when both phages select for similar
Fig 2. Relationships of cross-resistance range with relative fitness and the strength of focal resistance. Relationship between cross-resistance range (the
proportion of nonfocal phages to which the bacterial mutant has resistance above the binary threshold) and relative fitness of spontaneous resistance mutants (A)
measured as growth relative to the ancestral strain in phage-free standard media conditions (raw data provided in S2 Data) and (B) the strength of focal resistance,
given as growth in the presence of the phage selected against, relative to growth in the absence of phage (RBG). RBG, relative bacterial growth.
https://doi.org/10.1371/journal.pbio.2006057.g002
Evolution of cross-resistance
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006057 October 3, 2018 5 / 22
modifications to a shared receptor, whereas asymmetric cross-resistance could result if phages
selected for different modifications to a shared receptor that varied in the extent of disruption
or for entirely different resistance mechanisms that varied in the extent of generalism. To
study this at the genetic level, we next obtained whole-genome sequences for resistant mutants
selected against a subset of 10 focal phages that represented all nodes of the cross-resistance
network (S5 Fig).
Molecular basis of within- and between-module cross-resistance
We obtained whole-genome sequences for 22 independent spontaneous resistant mutants of
PAO1 selected against 10 focal phages to identify mutational changes associated with specific
phage resistance profiles (Fig 3; S5 Fig). Cross-resistance within module 2 was associated with
mutations in LPS biosynthesis genes wzy and wbpL, whereas cross-resistance within module 1
was associated with mutations in various genes encoding type IV pilus biosynthesis (Fig 3; S1
Table). These included genes encoding mechanical components of the type IV pilus, such as
the motor proteins PilB and PilT, and enzymes involved in type IV pilus biosynthesis and
assembly such as PilD, a prepilin peptidase. These data confirm that cross-resistance modules
were determined by distinct phage adsorption cell-surface receptors—specifically, the LPS for
module 2 phages and the type IV pilus for module 1 phages. We confirmed distinct receptor
usage by testing the ability of all 27 phages to infect an unpiliated pilB transposon mutant:
whereas module 1 phages were unable to form plaques on the unpiliated host, module 2 phages
infected the unpiliated mutant at the same efficiency as they infected the piliated wild-type
PAO1 host (all p> 0.1; S6 Fig; S4 Data). Between-module cross-resistance was associated with
mutations in genes encoding the transcriptional regulators RpoN and PilS (Fig 3; S1 Table).
This suggests that more generalist phage resistance required changes in bacterial gene regula-
tion, which are likely to have broader-scale effects on the bacterial phenotype than mutations
affecting structural genes performing steps in biosynthetic pathways. In addition, weaker
between-module cross-resistance was associated with a mutation of the prepilin peptidase–
Fig 3. Genetic basis of phage resistance. Circles represent different phage-resistant mutants selected against different focal phages (indicated by the colour shade;
see key), and dots on each circle show the position of mutated genes. Colour represents the cross-resistance profile of each sequenced resistant mutant: resistance
within module 1 (purple), within module 2 (green), and between modules (generalist resistance, blue).
https://doi.org/10.1371/journal.pbio.2006057.g003
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encoding gene pilD (S7 Fig); here the likely mechanism of between-module cross-resistance is
less clear.
Fitness cost of between-module cross-resistance is gene specific
To test if the different classes of resistance mutations identified by sequencing were associated
with different magnitudes of fitness cost, we estimated the fitness of each of the genome-
sequenced strains relative to PAO1 in the absence of phage. Between-module cross-resistance
was associated with higher fitness costs than within-module cross-resistance (Fig 4A; ANOVA
with post hoc Tukey test: module 1, p = 0.009; module 2, p = 0.015), but this was entirely due
to far-higher fitness costs caused by resistance mutations in the rpoN gene compared to resis-
tance mutations in either type IV pilus or LPS biosynthesis–associated genes (Fig 4B). Thus,
between-module cross-resistance mutations in global regulators that are likely to disrupt many
cellular functions are highly costly in the absence of phage, which may limit their long-term
survival in bacterial populations.
Fig 4. Relative fitness of resistant mutations grouped by cross-resistance type and mutational target. Fitness relative to the phage-susceptible PAO1 ancestor
of 263 spontaneous resistant mutants sorted by (A) cross-resistance type or (B) mutated locus. Colours denote cross-resistance type: within module 1 only
(purple), within module 2 only (green), and between modules (blue). The dashed line (relative fitness = 1) represents equal fitness to the ancestor.
https://doi.org/10.1371/journal.pbio.2006057.g004
Evolution of cross-resistance
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Cross-resistance determines the evolution of resistance to phage
combinations
We hypothesised that the degree and symmetry of cross-resistance between a pair of phages
would predict the frequency of resistance evolution against phage combinations. Specifically,
we predicted the highest frequency of resistance mutation would occur against pairs selecting
for symmetric cross-resistance, followed by asymmetric cross-resistance, and lowest for no
cross-resistance. To test this, we first estimated the frequency of resistance mutations against
phage pairs relative to individual phages for all possible combinations of the subset of 10
phages representing all nodes of the cross-resistance network (S5 Fig). One phage (PA5P2)
was excluded from further analysis because the absolute resistance mutation frequencies
observed against this phage were unfeasibly high (approximately 1.7 × 10−3 for PA5P2 alone;
S8 Fig). This could possibly indicate that a physiological mechanism of resistance against
PA5P2 infection exists, in addition to the LPS-associated mutational mechanism observed in
the sequenced resistant clone (Fig 3; S1 Table).
We found a positive relationship between the cross-resistance index (CRI; a nondirectional
measure of cross-resistance) and the relative mutation frequency (linear regression R2 = 0.280,
F1,106 = 42.7, p< 0.0001). Moreover, consistent with our hypothesis, the relative mutation fre-
quency was highest for phage pairs that selected for symmetric cross-resistance (Fig 5; sym-
metrical versus asymmetrical p = 0.001; symmetrical versus none p< 0.0001) and lowest for
phage pairs that selected no cross-resistance (Fig 5; asymmetrical versus none p< 0.0001).
Thus, cross-resistance per se increased the frequency of resistance mutations, with the effect
being strongest when cross-resistance was symmetric.
Consistent with the observed resistance mutation frequencies, phage pairs that selected no
cross-resistance suppressed the growth of PAO1 most effectively during 24 h, whereas the
effect of phage pairs that selected symmetric cross-resistance rarely differed from the best-per-
forming individual phage (S9 Fig; S6 Data). Two phages did not conform to this pattern:
Firstly, phage PA10P2 alone was sufficient to completely suppress bacterial growth, and all
pairs including this phage were highly effective regardless of the symmetry of the cross-resis-
tance. Secondly, phage pairs containing PA2P1 consistently performed poorly, irrespective of
the symmetry of cross-resistance. These results suggest that the structure of cross-resistance
predicts the performance of phage combinations but that strong phage identity effects can
override this by either increasing or decreasing the efficacy of a phage combination more than
expected by cross-resistance alone.
Discussion
We analysed the network structure and underlying genetic basis of cross-resistance evolution
in the bacterium P. aeruginosa PAO1 selected against 27 phages. Our data show that spontane-
ous resistance mutations against a focal phage commonly provide cross-resistance against
other phages. The cross-resistance network was highly modular, containing two cross-resis-
tance modules with high within- but weak between-module cross-resistance interactions. At
the genetic level, cross-resistance modules were defined by shared mutational targets encoding
biosynthesis of phage adsorption receptors (LPS or type IV pilus, respectively), whereas
between-module cross-resistance was associated with mutations targeting regulatory genes.
The strength, direction, and symmetry of cross-resistance between phage pairs predicted both
the frequency of resistance mutation and the efficacy with which the phage pair suppressed
bacterial growth: the highest-performing phage combinations were those that selected no
cross-resistance, whereas the lowest-performing combinations selected symmetric cross-resis-
tance. Taken together, these data suggest that cross-resistance will commonly shape the
Evolution of cross-resistance
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dynamic structure of bacteria–phage communities and that it is likely to be an important pre-
dictor of the robustness of phage therapy to resistance evolution. Further experiments will be
required, however, to test whether cross-resistance predicts the efficacy of phage cocktails in
more complex in vivo environments.
Our finding that cross-resistance was common for our phage collection suggests that resis-
tance evolution events may frequently disrupt the structure of bacteria–phage interaction
networks. Cross-resistance evolution has the effect of reducing connectance at the whole-com-
munity level more than would be expected if all interactions were strictly pairwise. The effect
of connectance on community stability is dependent on underlying species interaction net-
work architecture; reduced connectance can increase stability in trophic networks by enhanc-
ing modularity but may reduce stability in networks with nested structures [22]. Bacteria–
Fig 5. Relative mutational frequency for resistance against phage pairs exerting symmetrical, asymmetrical, or no
cross-resistance. Relative mutational frequency compares the frequency of resistance mutations against phage pairs to
the geometric mean of mutational frequency against each individual phage. Dashed line represents equal frequency of
resistance mutations against a phage pair versus the constituent phages individually. Raw data are provided in S5 Data.
https://doi.org/10.1371/journal.pbio.2006057.g005
Evolution of cross-resistance
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phage networks typically have a nested-modular network structure [23,24]; thus, the impact of
cross-resistance-mediated reduced connectance is likely to depend on precisely where in the
network cross-resistance interactions occur. It seems reasonable to assume that modularity in
bacteria–phage interaction networks may be caused by the same mechanism that causes cross-
resistance modularity—namely, shared phage receptors. If this assumption is correct, then
cross-resistance evolution may frequently lead to the collapse of isolated nested modules with-
out destabilising the broader interaction network. Resistance in our experiments arose largely
through mutations affecting the expression or biosynthesis of surface receptors. Notably,
PAO1 lacks a CRISPR system, and it is likely that CRISPR-mediated phage resistance would
cause cross-resistance to only very closely related phages that are sequence identical for the
genomic region targeted by the newly integrated spacer. In systems where both resistance
mechanisms occur, the mechanism by which resistance evolves is thought to depend on eco-
logical conditions, with surface receptor modification favoured in high-resource environments
with high phage densities [25], suggesting that in such systems, the structure of cross-resis-
tance evolution may be highly ecologically contingent.
While resistance mutations were costly, we found no overall relationship between the range
of cross-resistance provided by resistance mutations and their associated fitness costs, suggest-
ing that the evolution of cross-resistance is unlikely to be constrained by fitness trade-offs
except for rare cases of very generalist between-module cross-resistance (Fig 4B). This finding
is somewhat surprising, since previous studies of pairwise bacteria–phage interactions and
interactions between bacteria and multiple phage species have reported that broader resistance
ranges are associated with higher costs [7,26]. In contrast to these studies, however, we did not
allow broad resistance ranges to evolve via accumulation of multiple sequential mutations but
instead measured the effects of single spontaneous resistance mutations on cross-resistance. It
seems likely therefore that higher costs of generalist phage resistance described previously
arise from negative epistasis between multiple resistance mutations rather than from inherent
costs of cross-resistance itself. At a community level, cross-resistance could limit the ability of
phages to maintain bacterial diversity via density dependent killing [27]. This could be miti-
gated by migration between local communities, promoting invasion of novel phages to which
resistance is absent in the local community, or through phage counteradaptation. For example,
phages have been shown to switch hosts in multihost environments [4] and expand host range
through spontaneous mutation [28,29]. An important caveat is that fitness costs measured in
simple lab environments are likely to underestimate the full extent of the pleiotropic effects of
resistance mutations in more complex in vivo environments relevant to phage therapy. For
example, loss of the type IV pilus is likely to be highly detrimental in vivo where type IV pilus–
mediated motility, attachment, and biofilm formation play important roles in pathogenesis
[30].
The modular structure of the cross-resistance network was determined by the shared phage
receptors modified by resistance mutations. Within cross-resistance modules, mutations tar-
geted biosynthesis of specific surface receptor targets for phage binding (S1 Table), specifically
the type IV pilus in module 1 or the LPS biosynthesis in module 2. Resistance to the same
phage could be provided by mutations to different genes in the same pathway. For example,
mutations selected against phage PA5P2 affected PilD (a peptidase that processes prepilins;
[31]), PilQ (which is involved in assembly and transport; [32]), and PilT (a motor protein that
powers pilus retraction; [33]). By contrast, mutations that provided very generalist between-
module resistance targeted the regulatory genes rpoN and pilS. RpoN is an alternative sigma
factor that regulates transcription of approximately 700 genes, influencing a diverse range of
functions, including motility (via both type IV pilus–and flagella-associated genes), quorum
sensing, mucoidy, and biofilm formation [34]. PilS is part of a two-component regulatory
Evolution of cross-resistance
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006057 October 3, 2018 10 / 22
system that promotes pilus expression by activating RpoN [35]. The diverse regulatory func-
tion of RpoNmakes it difficult to identify the specific mechanism of generalist phage resis-
tance. However, RpoN regulation of LPS-associated genes has been identified in P. aeruginosa
(rfaD; [34]) and shown to directly influence LPS expression in Salmonella enterica (via rfaH;
[36,37]). It is possible, therefore, that global regulatory mutations affecting the expression of
multiple phage receptors could be typical for very generalist phage resistance. Crucially, only
less than 10% of resistance mutants possessed generalist cross-resistance against both LPS and
pilus binding phages, which suggest that these mutations are rarer. This is intuitive, since there
are many more mutational targets in each biosynthesis pathway compared to the single copy
of the rpoN gene. Moreover, the evolutionary success of global regulator-mediated resistance
may be limited by the extensive pleiotropic effects of such mutations on the bacterial pheno-
type. Consistent with this, rpoNmutants suffered the greatest impairment in growth rate of all
the observed resistance mutations (Fig 4B). Between-module cross-resistance could be
achieved at lower cost through mutations affecting pilS, which were no more costly than other
resistance mutations in type IV pilus–associated genes, suggesting that loss of PilS-mediated
activation of RpoN may have been less disruptive to the cell than loss of RpoN itself. Because
RpoN controls expression of important virulence-related functions such as quorum sensing
and biofilm formation, phage combinations that select for these mutations may concomitantly
drive reduced virulence.
We observed that asymmetric cross-resistance was common within our cross-resistance
network. Reducing the threshold used to define resistance further increased asymmetric con-
nections between modules (S3 Fig), suggesting that asymmetric cross-resistance may often be
rather weak. While the mechanistic basis of symmetric cross-resistance appears conceptually
straightforward—the two phages select for similar modifications to and/or loss of a shared
receptor (for instance, via LPS modification [15])—the situation is likely to be more complex
for asymmetric cross-resistance. We propose two potential routes to asymmetric cross-resis-
tance: First, phages may select qualitatively different mechanisms of resistance offering differ-
ent degrees of generality; for example, one phage may select for mucoidy [38,39], masking a
number of different phage receptors thus providing cross-resistance, whereas the other phage
may select for modification of a specific receptor only and limited cross-resistance. Second,
resistance mutations for each phage may target different points in a biosynthesis pathway,
such that mutations affecting the start of the pathway will provide greater cross-resistance than
those affecting targets downstream [40]. Consistent with the latter mechanism, within module
1, the observed mutations in rpoN, which are likely to result in an unpiliated phenotype, pro-
vided complete cross-resistance within module 1, whereas mutations to genes lower down the
pilus biosynthesis pathway (for instance, pilB and pilT encoding motor proteins that control
extension and retraction of the pilus respectively; [33]) provided cross-resistance to only half
of the module 1 phage. Understanding the mechanistic basis of cross-resistance in general,
and the symmetry of cross-resistance in particular, should be a target of future research.
Our findings show that cross-resistance and its symmetry predict the efficacy of phage com-
binations both in terms of the frequency of resistance mutation and the efficiency of suppres-
sion of bacterial growth. Frequencies of resistance mutation were the highest for phage pairs
with symmetric cross-resistance and the lowest for phage pairs that showed no cross-resis-
tance, suggesting either multistep mutational changes or rarer generalist resistance mutations
were required in the latter scenario. Consequently, phage pairs that exerted no cross-resistance
often completely supressed bacterial growth, whereas failure to supress bacterial growth was
more common for phage pairs that promoted some degree of cross-resistance evolution. Our
analysis also identified individual phage strains that increased (or decreased) the performance
of phage combinations more than predicted by cross-resistance alone. Although we observed
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an overall positive association between the strength of focal resistance and the strength of
cross-resistance, in some cases, focal resistance caused by a mutation was quantitatively weaker
than the cross-resistance(s) or undetectable. Since spontaneous resistant mutants have not had
the opportunity to specialise their resistance against the focal phage, it is perhaps unsurprising
that stronger cross-resistance can arise by chance. More puzzling are the cases of undetectable
focal resistance despite there being observable cross-resistance and a resistance mutation iden-
tified in the genome sequence. This phenomenon was limited to particular phages: ϕKZ (pilR
mutation), PA5P1 (wzymutation), and PT7 (pilS, pilT, and pilJmutations). Although we do
not understand the mechanism underlying missing focal resistance, it is possible that this
could be caused by extremely high rates of phage evolution to overcome the resistance muta-
tion during the RBG assay, or particular phages being able to use an alternative surface recep-
tor [41]. This suggests that other properties of phage life history are likely to affect their
usefulness in phage combinations and that predictions based on cross-resistance networks
could be sensitive to strong phage identity effects.
P. aeruginosa is a common cause of opportunistic infections, frequently of burn wounds,
and is also the major pathogen associated with chronic infections of the cystic fibrosis (CF) air-
way [42–45]. High-level antibiotic resistance frequently makes P. aeruginosa CF infections
nonresponsive to antibiotic treatments and consequently very difficult to eradicate [46]. As a
result, phage therapy has been suggested as a potential alternative or complementary treatment
[47–49]. Phage therapy has shown promising results against P. aeruginosa in both artificial CF
lung sputum–like environments and murine models [50]. However, clinical trials of phage
therapy on P. aeruginosa–colonised burn wounds have proved inconclusive thus far [51,52].
Our results suggest that unknown patterns of cross-resistance selected by the phages used in
therapeutic cocktails could account for some degree of variation in the efficacy of phage thera-
pies in these studies. Using combinations of phages that do not select for cross-resistance
could potentially improve the efficacy and robustness of phage cocktails, increasing their abil-
ity to suppress bacterial growth by limiting resistance evolution. While caution is required
when making inferences from simple lab experiments to far more complex in vivo environ-
ments, our data suggest that analysis of cross-resistance networks could aid the design process
for improved therapeutic phage cocktails and warrants future in vivo experimental tests.
Materials and methods
Study organisms
A total of 27 different phage strains (S2 Table) that were able to infect P. aeruginosa PA01
strain were used. Four of the phage strains have been previously characterised and are known
to be phylogenetically, structurally, and serologically different [53,54] and promote bacterial
resistance evolution to differing degrees [14]. The remaining 23 phage strains were isolated at
the same time and location (sewage water treatment facility, Jyva¨skyla¨, Finland; for isolation
protocols and infectivity ranges, see [55]). Sequence data are available for only two of these
strains.
Characterisation of phage genetic relatedness
The genetic similarity of all phage strains was characterised using RAPD PCR that uses a set of
primers (S3 Table) to amplify random sections of DNA, giving a unique PCR banding pattern
for each distinct phage genotype. Phage DNA was extracted using the QIAamp DNAMini Kit
(Qiagen, Hilden, Germany), and then a PCR was performed on each phage DNA sample (27
phages), with each primer (0.8 μm final primer concentration; S3 Table) under the following
conditions: 4 initial cycles of 94 ˚C for 45 s, 30 ˚C for 120 s, and 72 ˚C for 60 s, followed by 25
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cycles of 94 ˚C for 5 s, 30 ˚C for 30 s, and 72 ˚C for 30 s, ending with 72 ˚C for 10 min. PCR
products were run on 1% Agarose gels for 30 min at 200 V. A difference matrix based on these
banding patterns (i.e., the proportion of bands that two phages do not have in common) was
used to make a neighbour-joining tree (R package ‘ape’, [56]).
Culture conditions
All bacterial cultures were grown in 6 ml King’s media B (KB) in 30-ml glass microcosms with
loose-fitting plastic lids and incubated at 37 ˚C with orbital shaking (200 rpm). Phage cultures
were prepared by inoculating frozen stocks into 30-ml microcosms containing 6 ml KB with
60 μl of PA01 overnight culture (approximately 109 cells ml−1). Following overnight incuba-
tion at 37 ˚C, shaken, phage stocks were isolated by filtration (0.22 μm) and stored at 4 ˚C.
Selecting spontaneous phage-resistant mutants
To select spontaneous phage-resistant mutants, a modified fluctuation test was used [57]. To
establish 135 independent subpopulations of PAO1, we selected a single colony and incubated
for 8 h before diluting by 1 in 10 into individual wells of 96-well microplates containing 200 μl
of KB medium. Following overnight incubation, each of the bacterial populations was exposed
to one of the 27 phages. Specifically, the overnight bacterial cultures were diluted by 10−2
directly into 200 μl of a phage stock solution, giving a multiplicity of infection of approximately
100 phage particles per bacterial cell and 5 independent bacterial populations per phage strain.
From each bacteria–phage mixture, 100 μl was plated on KB solid agar and incubated over-
night. Two colonies per plate were then restreaked onto KB agar plates and grown overnight
to remove phage particles. We then picked a single colony from each streak plate to give 10
resistant mutants per phage strain (270 in total), which were then grown overnight in KB
before preparing glycerol stocks (40% glycerol) and storing at −80 ˚C. These overnight cultures
were also filter sterilised (0.22 μm) and plated on KB soft agar (0.8%) containing ancestral
PA01 to check for any remaining phage particles. If phages were detected, phage-free stocks
were created by restreaking the resistant mutant from glycerol stocks and repeating the last
step. For seven replicates, we were unable to isolate phage-free stocks; therefore, these repli-
cates were excluded from the analysis, leaving 263 resistant mutants in total.
Cross-resistance assays
To assess the extent of cross-resistance conferred by resistance against individual phage strains,
all 263 resistance mutants were assayed against each of the 27 phage strains individually.
Cross-resistance assays were performed in 96-well microplates (final volume of 150 μl) in KB
media, at an approximate multiplicity of infection of 10 phage particles per bacterial cell. The
RBG [58] was calculated by comparing absorbance readings (600 nm at t = 0 and t = 8 h) in
the presence and absence of phage (Eq 1). RBG is a quantitative measure of bacterial resistance
in which 1 indicates equal growth in the presence and absence of phage (i.e., complete resis-
tance), and 0 indicates zero growth (i.e., complete susceptibility).
For phage i, bacteria j:
RBGij ¼
½Abs
600
ðt ¼ 8 hÞ   Abs
600
ðt ¼ 0 hÞij
½Abs
600
ðt ¼ 8 hÞ   Abs
600
ðt ¼ 0 hÞcontrolj
ð1Þ
Cross-resistance range describes the proportion of phages to which each resistant bacterial
replicate mutant is resistant to, using a resistance threshold (RBG = 0.798) calculated as the
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95% confidence interval of a normal distribution modelled over the peak of resistance within
the complete RBG distribution (S1 Fig).
Measuring the fitness costs associated with cross-resistance
To determine the fitness costs associated with different cross-resistance profiles, the growth of
all resistant mutants was measured in the absence of phage and compared to growth of the
ancestral PA01 strain. Bacterial cultures were inoculated directly from glycerol stocks into
150 μl of KB media in 96-well microplates. Absorbance at 600 nm was measured every 30 min
for 24 h (37 ˚C, shaken) to create a growth curve for each resistant mutant. Because of varia-
tion in the type of fitness costs observed (i.e., increased lag, reduced maximum OD, and
reduced growth rate; S10 Fig), we used the integral of each growth curve as a combined mea-
sure of the effect of resistance mutations on bacterial growth. The integral of the growth curve
correlates well with each of the other growth parameters (S11 and S12 Figs). The integral of
each growth curve gives the total growth for each bacterial strain; dividing this value by the
average integral for the ancestral PA01 strain gives an estimate of relative fitness.
Determining the cross-resistance network
Cross-resistance interactions between two phage strains can be quantified as the proportion of
resistance mutants screened against one phage that display cross-resistance (RBG above 0.798)
against the second phage, giving a directional metric of cross-resistance strength (CRF). To
enable comparison of pairwise phage interactions, a nondirectional CRI was used as the mean
of the two directional CRF values.
CRF can be used to construct an interaction network showing all directional cross-resis-
tance interactions within a phage community. Firstly, an adjacency matrix is produced, con-
taining directional CRF values for all possible phage pairs. The R package ‘igraph’ [59] was
used to convert the adjacency matrix into a network graph (a list of all the realised links in
the network and their associated weights; graph.adjacency function), which can then be plot-
ted (plot.igraph function) as a directional weighted network. In the network, each node repre-
sents a single phage strain, and the directional connections are weighted by CRF, showing
the frequency of cross-resistance against each phage. A community-detection algorithm
(cluster_edge_betweenness function in the ‘igraph’ R package [59]) was used to identify the
phage strains within the cross-resistance network that formed modules. This edge-between-
ness algorithm [60,61] finds the optimum community structure of a given network by assign-
ing a ‘betweenness’ value to every link in the network based on the frequency with which the
link is used to create pathways between all possible pairs in the network. High ‘betweenness’
values indicate links between poorly connected modules. By removing these links in a stepwise
manner (recalculating ‘betweenness’ values each time), the algorithm can define modules
within the community. The subnetwork of the 10 phages used in further analysis was extracted
from this full network.
Quantifying the frequency of phage resistance mutations
Modified fluctuation tests [57] were used to estimate bacterial mutation frequencies against
either individual phage strains or combinations of two phage strains. Three microcosms were
inoculated from single colonies of the ancestral PA01 strain. After overnight incubation, each
microcosm was subcultured into 55 wells of a 96-well microplate, diluting by 10−1 to a final
volume of 200 μl, and then allowed to grow overnight at 37 ˚C in a static incubator. Concur-
rently, stock solutions of 10 phage strains (a subset representing each node within the CRF net-
work; S5 Fig) were prepared (as above). Phage combinations were assembled, consisting of
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each phage alone (100 μl) and 1:1 mixtures of each possible phage pair (final volume 100 μl), to
give 55 different phage combinations. One independent 200 μl PA01 culture from each of the
three replicate microplates was then diluted 100-fold into each of the phage solutions, giving a
multiplicity of infection of approximately 100 phage particles per bacterial cell, and incubated
for 30 min at 37 ˚C in a static incubator.
Initial bacterial cell density was estimated by plating serial dilutions of 6 random 200 μl
PA01 cultures per replicate microplate. The number of phage-resistant spontaneous mutants
was then calculated by plating 60 μl of each bacteria–phage mixture onto solid KB agar to give
colony-forming units per ml (CFU/ml). The ratio of phage-resistant mutants to initial bacterial
cell density provides an estimate of the mutational frequency (MF, Eq 2) against each phage
combination, and then comparison to the individual phage strains gives relative mutational
frequency (RMF, Eq 3).
For phage suspension i, bacteria j:
MFi ¼
½CFU=mlij
½CFU=mlcontrolj
ð2Þ
For phage pair i1 and i2,
RMF ¼ MFi1i2ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
MFi1:MFi2
p ð3Þ
Suppression of bacterial growth by phage combinations
To determine the ability of phage combinations to suppress growth of the ancestral PA01
strain, bacterial growth was measured over 24 h in the presence of individual phage strains
and all possible pairwise phage combinations of 10 phage strains. This phage subset contains
all 4 phages from module 1 and 6 module 2 phages (S5 Fig) and is comprised of asymmetric
(N = 11) and symmetric (N = 13) cross-resistance interactions, as well as pairwise interactions,
which promote no cross-resistance (N = 21). Individual colonies of ancestral PA01 were inocu-
lated into KB media and, following overnight incubation, were transferred to fresh KB media
in 96-well microplates, diluting 10-fold. Phage suspensions were added at an approximate
multiplicity of infection of 100 for both individual phage and pairwise phage combination
treatments (prepared from phage stock solutions with a 1:1 ratio). Absorbance at 600 nm was
measured every 30 min for 24 h during incubation at 37 ˚C with regular orbital shaking to pro-
duce growth curves for PA01 in the presence of each individual phage strain and all possible
pairwise phage combinations within the phage subset (S5 Fig), each replicated three times.
Sequence analysis
To assess the genetic basis of cross-resistance, we randomly chose one resistant mutant
screened against each phage within the cross-resistance subnetwork (S5 Fig), along with addi-
tional mutants representing symmetrical and asymmetrical cross-resistance profiles within
resistance module 1, to be sequenced (22 independent spontaneous mutants in total). Bacteria
were sequenced using the Illumina MiSeq platform, followed by bioinformatic analysis as fol-
lows: reads were aligned using Burrows-Wheeler Aligner [62], SNPs and small indel variants
were called by GATK HaplotypeCaller [63], and then gene information was added using
SNPeff [64]. Variants were filtered for quality by the following parameters: coverage of>20
reads per base pair and frequency of alternative allele in>80% of reads. The quality of each
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variant was further assessed visually using an alignment viewer (igv; [65]). Additionally, called
variants occurring in all 22 sequenced mutants were discarded, as these represent mutations
present in the ancestral PAO1 compared to the available reference strain used (accession ID
AE004091). All sequence data have been uploaded to the European Nucleotide Archive (acces-
sion ID PRJEB27828).
Confirmation of phage surface receptor targets
To confirm that distinct cell surface receptors are required for infection by module 1 phages
compared to module 2, we tested the ability of all 27 phage strains to infect a pilB transposon
mutant (PW8623 pilB-G07::ISlacZ/hah; P. aeruginosa Two Allele Library) versus wild-type
PAO1. Bacteria lawns were prepared as follows: three colonies were selected for each bacterial
strain, inoculated into KB media (6 ml), and grown overnight at 37 ˚C, shaken; 200 μl of each
culture was added to 12 ml of soft KB agar (0.6% agar) and poured over set standard KB agar
(1.2% agar) in a 120-mm square petri dish to form a bacterial lawn. Filtered phage stocks were
serially diluted, and each dilution was spot plated (5 μl) onto a lawn of each bacteria. Plates
were incubated at 37 ˚C for 24 h, and then phage plaques were counted and density calculated
as plaque-forming units per ml.
Statistical analysis
All analysis was conducted in R [66]. Resistant mutants originating from the same subpopula-
tion were treated as paired replicates to prevent pseudoreplication. This means for 263 resis-
tant mutants, we have 133 independent replicates. Variation in cross-resistance range between
different focal phages was analysed using the nonparametric Kruskal-Wallis test, after averag-
ing within subpopulations. To test for associations between cross-resistance range and focal
resistance or relative fitness, linear mixed effects models (R package ‘lmerTest’ [67]) were
used, with subpopulation included as a random effect. Variation in relative fitness between
mutants with different network-level cross-resistance (i.e., within/between modules) was ana-
lysed using a one-way ANOVA followed by post hoc testing (Tukey test). Comparison of
phage densities between transposon mutant (pilB) and wild-type hosts was performed using a
linear mixed effects model, with bacteria and phage treated as interacting fixed effects. Statisti-
cal analysis of the effect of cross-resistance interaction type (i.e., symmetric/asymmetric) on
RMF data was performed using the Kruskal-Wallis test, followed by post hoc testing (pairwise
Mann-Whitney U) to compare interaction types.
Supporting information
S1 Fig. RBG distribution and definition of the binary resistance threshold. The frequency
histogram shows the RBG values for 263 resistant mutants against all 27 phages. The blue
curve shows the normal distribution of the resistance peak (RBG = 1). The threshold of binary
resistance was calculated as the 95% confidence interval of the normal distribution (blue
dashed line; RBG = 0.798). RBG, relative bacterial growth.
(EPS)
S2 Fig. Bacteria–phage infection network. Infection network showing resistance profiles of
spontaneous mutants selected against individual phage. Spontaneous PA01 mutants are
grouped so that each row represents up to 10 replicates selected against the same phage. Each
column denotes individual phage strains that mutants were individually challenged against.
Colour shading corresponds to the proportion of replicates that were susceptible to the
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corresponding phage (see key).
(EPS)
S3 Fig. Cross-resistance network structure at different binary resistance thresholds. Num-
ber and type of links between phage pairs within and between each cross-resistance module
for different values of the binary threshold of resistance.
(EPS)
S4 Fig. Characterisation of phage genetic diversity. (A) Banding patterns produced by
RAPD PCR analysis of 27 phages (columns) by the molecular weight of PCR products from 9
different primers (rows; S3 Table). (B) Difference matrix summarising the dissimilarity of
banding patterns between phages (i.e., 1 − proportion of bands in common). (C) Neighbour-
joining tree produced from the phage dissimilarity matrix. RAPD, random amplified polymor-
phic DNA.
(EPS)
S5 Fig. Cross-resistance subnetwork. A subset of the cross-resistance network showing all
pairwise cross-resistance interactions between the 10 phage strains used in the mutational fre-
quency experiment and the suppression of bacterial growth assays.
(EPS)
S6 Fig. Phage infection of PAO1 versus a pilB transposon mutant. Plaque-forming units per
ml when plated on the piliated wild-type (black; ‘Ancestor’) and the unpiliated pilB transposon
mutant (grey).
(EPS)
S7 Fig. Cross-resistance profiles of sequenced resistant mutants. Bacteria–phage infection
network showing sequenced resistant mutants where gene location of SNPs is identified
(rows), against 27 phage strains (columns). Strength of resistance (RBG) scales from complete
resistance (white) to complete susceptibility (dark blue). RBG, relative bacterial growth.
(EPS)
S8 Fig. Absolute frequencies of resistance mutations against phage pairs. Frequency of
resistance mutations against single phage (+) and phage pairs coloured by cross-resistance
type associated with each phage pair (blue—no cross resistance; green—asymmetrical cross-
resistance; red—symmetrical cross-resistance).
(EPS)
S9 Fig. Suppression of bacterial growth by phage monocultures and pairwise phage
combinations. Bacterial density was measured as OD (600 nm, y-axis) over 24 h (x-axis) in
the presence of single phages (white background) or two phages (grey backgrounds). Dark
grey background denotes phage pairs that exert symmetric cross-resistance, mid grey for
phage pairs that show asymmetric cross-resistance, and light grey for no observed cross-
resistance.
(EPS)
S10 Fig. Growth curves showing the fitness impact of resistance mutations. Growth curves
of all 263 spontaneous resistant mutants grouped by focal phage resistance (up to 10 mutants
per focal phage) and the wild-type ancestor (PAO1).
(EPS)
S11 Fig. Frequency histograms of growth parameters for PAO1 and resistant mutants. Fre-
quency histograms of growth parameters extracted from the bacterial growth curves (S10 Fig):
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maximum absorbance reached in 24 h (OD600), lag period calculated as x-axis intercept
(time, hours) of a tangent to the growth curve at the point of maximum growth rate, maximum
growth rate, and integral of growth curve. Red histogram shows the wild-type PAO1 ancestor,
and blue shows 263 spontaneous resistant mutants.
(EPS)
S12 Fig. Correlation of growth parameters.Multiple linear regression of growth parameters
for 263 spontaneous resistant mutants (S11 Fig): the diagonal shows the distribution of each
growth parameter, the bottom quadrant plots correlations for each pair of growth parameters,
and the top quadrant gives corresponding R2 values.
(EPS)
S1 Table. Mutations identified by whole-genome sequencing of spontaneous resistant
mutants. Those highlighted in blue show mutations providing between-module cross-resis-
tance.
(PDF)
S2 Table. Overview of phage strains.Details of the isolation and characterisation of the phage
collection.
(PDF)
S3 Table. RAPD PCR primers. Primers used in the RAPD PCR analysis of phage genetic
relatedness. RAPD, random amplification of polymorphic DNA.
(PDF)
S1 Data. Growth data for bacterial cultures grown with or without phage used to calculate
RBG.
(TXT)
S2 Data. Growth data for bacterial cultures used to calculate relative fitness.
(TXT)
S3 Data. RAPD PCR banding patterns for the phages used in this study.
(TXT)
S4 Data. Plaque forming units of the phages when plated onto the piliated wild-type PAO1
or the unpiliated pilB transposon mutant.
(TXT)
S5 Data. Resistance mutation frequency for PAO1 against individual and pairwise combi-
nations of phages.
(TXT)
S6 Data. Growth data for bacterial cultures grown with or without indivdual or pairwise
combinations of phages.
(TXT)
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